These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Successful treatment of polymicrobial calcaneal osteomyelitis with telavancin, rifampin, and meropenem. Brinkman MB; Fan K; Shiveley RL; Van Anglen LJ Ann Pharmacother; 2012 Jun; 46(6):e15. PubMed ID: 22619476 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model. Yin LY; Calhoun JH; Thomas TS; Wirtz ED J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292 [TBL] [Abstract][Full Text] [Related]
9. Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN Trials. Nogid B; Lacy MK; Jacobs M; Bruss J; Dwyer J Pharmacotherapy; 2018 Oct; 38(10):990-998. PubMed ID: 30003567 [TBL] [Abstract][Full Text] [Related]
10. Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus. Corey GR; Rubinstein E; Stryjewski ME; Bassetti M; Barriere SL Clin Infect Dis; 2015 Mar; 60(5):787-96. PubMed ID: 25472944 [TBL] [Abstract][Full Text] [Related]
11. Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series. Bernstein AT; Leigh MW; Goralski JL; Esther CR; McKinzie CJ J Cyst Fibros; 2018 Nov; 17(6):e48-e50. PubMed ID: 30170755 [TBL] [Abstract][Full Text] [Related]
12. The role of telavancin in the treatment of MRSA infections in hospital. Bassetti M; Mikulska M; Righi E; Nicolini L; Viscoli C Expert Opin Investig Drugs; 2009 Apr; 18(4):521-9. PubMed ID: 19335280 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus. Madrigal AG; Basuino L; Chambers HF Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918 [TBL] [Abstract][Full Text] [Related]
14. Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus. McKinnell JA; Corman S; Patel D; Leung GH; Gordon LM; Lodise TP Clin Ther; 2018 Mar; 40(3):406-414.e2. PubMed ID: 29454592 [TBL] [Abstract][Full Text] [Related]
16. A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections. Chan C; Hardin TC; Smart JI Future Microbiol; 2015; 10(8):1325-38. PubMed ID: 26083676 [TBL] [Abstract][Full Text] [Related]